Featuring a slide presentation and related discussion from Dr Seth Wander, including the following topics:
- Biological impact of clinically relevant biomarkers (eg, ESR1 mutations, PIK3CA/AKT1/PTEN alterations) (0:00)
- Methodologies for biomarker assessment in clinical practice: Tissue versus liquid biopsy (5:21)
- Methodologies for biomarker assessment in clinical practice: Novel platforms (13:56)
- Appropriate timing for assessment of ESR1 and PI3K pathway alterations (17:34)
- Evolving guidelines for routine biomarker evaluation (21:37)
- Implications of precision oncology clinical trials for future biomarker utility (25:07)
- Summary, key questions, future directions (33:09)
CME information and select publications
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
